文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.

作者信息

Kigozi Jesse, Jowett Sue, Lewis Martyn, Barton Pelham, Coast Joanna

机构信息

Health Economics Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Health Economics Unit, Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

出版信息

Value Health. 2017 Mar;20(3):496-506. doi: 10.1016/j.jval.2016.12.006. Epub 2017 Jan 30.


DOI:10.1016/j.jval.2016.12.006
PMID:28292496
Abstract

OBJECTIVE: Given the significant costs of reduced productivity (presenteeism) in comparison to absenteeism, and overall societal costs, presenteeism has a potentially important role to play in economic evaluations. However, these costs are often excluded. The objective of this study is to review applied cost of illness studies and economic evaluations to identify valuation methods used for, and impact of including presenteeism costs in practice. METHODS: A structured systematic review was carried out to explore (i) the extent to which presenteeism has been applied in cost of illness studies and economic evaluations and (ii) the overall impact of including presenteeism on overall costs and outcomes. Potential articles were identified by searching Medline, PsycINFO and NHS EED databases. A standard template was developed and used to extract information from economic evaluations and cost of illness studies incorporating presenteeism costs. RESULTS: A total of 28 studies were included in the systematic review which also demonstrated that presenteeism costs are rarely included in full economic evaluations. Estimation and monetisation methods differed between the instruments. The impact of disease on presenteeism whilst in paid work is high. CONCLUSIONS: The potential impact of presenteeism costs needs to be highlighted and greater consideration should be given to including these in economic evaluations and cost of illness studies. The importance of including presenteeism costs when conducting economic evaluation from a societal perspective should be emphasised in national economic guidelines and more methodological work is required to improve the practical application of presenteeism instruments to generate productivity cost estimates.

摘要

相似文献

[1]
The Estimation and Inclusion of Presenteeism Costs in Applied Economic Evaluation: A Systematic Review.

Value Health. 2017-3

[2]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Health Technol Assess. 2001

[3]
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.

Health Technol Assess. 2006-3

[4]
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Health Technol Assess. 2006-9

[5]
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Health Technol Assess. 2008-6

[6]
Home treatment for mental health problems: a systematic review.

Health Technol Assess. 2001

[7]
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.

Health Technol Assess. 2001

[8]
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.

Health Technol Assess. 2001

[9]
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.

Health Technol Assess. 2006-3

[10]
The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer: systematic review and economic evaluation.

Health Technol Assess. 2008-5

引用本文的文献

[1]
Including Productivity as an Element to Reflect Value of the Treatment: A Systematic Review of Published Health Economic Evaluations.

Pharmacoecon Open. 2025-6-24

[2]
The Economic Implications of Psychosocial Peer Support for Health Workers in German Hospitals.

J Healthc Leadersh. 2025-1-25

[3]
Reference intervals of work ability and productivity loss and their use in patients with inflammatory rheumatic and musculoskeletal diseases.

RMD Open. 2025-1-6

[4]
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey.

Pharmacoecon Open. 2025-3

[5]
Explaining presenteeism behaviour with the theory of planned behaviour - a longitudinal study.

Int Arch Occup Environ Health. 2024-12

[6]
Social Costs of Smoking in the Czech Republic.

Appl Health Econ Health Policy. 2025-1

[7]
Quantifying value loss due to presenteeism and absenteeism in workers' compensation spinal patients.

N Am Spine Soc J. 2024-7-20

[8]
Prevalence of sickness presenteeism and associated factors among primary school teachers in Gondar city, northwest Ethiopia.

Front Public Health. 2024

[9]
Female teleworkers with pain have the highest presenteeism, where its primary contributing variable was not those of musculoskeletal disability.

Ind Health. 2025-1-24

[10]
Work ability and return-to-work of patients with post-COVID-19: a systematic review and meta-analysis.

BMC Public Health. 2024-7-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索